brexit
Sanofi may airlift flu vaccines into UK after Brexit
March 26, 2019Manufacturing and Production EU, France, Sanofi, UK, brexit, channel tunnel, vaccines
French firm Sanofi would airlift flu vaccines into the UK in the case of a highly disruptive exit from the …
Top Ten most popular articles on Pharmafile.com this week!
March 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Acadia Pharmaceuticals, FDA, Sandoz, brexit, genomics, pharma, pharmacovigilance, top 10
The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia …
Healthcare industry could take up to five years to stabilise after no-deal Brexit
March 13, 2019Manufacturing and Production, Medical Communications, Research and Development GlobalData, analysis, brexit, no-deal Brexit, surveys
The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to …
More than 40% of GPs intend to quit within five years
February 28, 2019Medical Communications GPs, NHS, NHS LOng term plan, UK, brexit, workforce
More than 40% of GPs intend to quit within five years according to researchers at the University of Warwick. The …
Read the March 2019 issue of Pharmafocus online now!
February 26, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Drug pricing, HIV, Trump, WHO, brexit, depression, mental health, pharmacovigilance, rare disease
Just one month to go until Brexit here in the UK, and it’s still all to play for. After months …
FMD would not apply in case of no-deal Brexit
February 8, 2019Medical Communications EU, FMD, UK, brexit, falsified medicines
The Falsified Medicines Directive would be scrapped in the event of a no deal Brexit, the Association of the British …
Read Pharmafocus January/February 2019 edition online now!
January 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines
We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; …
Novartis warns of huge impact of no-deal Brexit
January 28, 2019Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma
Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …
Government unveils £20bn plan to revitalise NHS in England
January 8, 2019Manufacturing and Production NHS funding, NHS< funding, brexit, government, health, policy
Theresa May and the chief executive of NHS England, Simon Stevens, have announced a new ten year plan for the …
Top Ten most popular articles on Pharmafile.com of 2018!
December 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Business, biosimilars, brexit, pharma, top 10
Brexit, business and biosimilars, seemed to be the three themes of 2018. As Brexit negotiations reached a stalemate the pharmaceutical …
Top Ten most popular articles on Pharmafile.com this week!
December 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Eli Lilly, Novartis, Teva, Tilray, brexit, celltrion, pharma, top 10
Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …
No-deal Brexit stockpiling puts pressure on supply chain
December 17, 2018Sales and Marketing brexit, no-deal, pharma, pricing, supply chain
The stockpiling of medicines in preparation for a no-deal Brexit is putting pressure on the supply chain and causing shortages …
Top Ten most popular articles on Pharmafile.com this week!
December 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cancer, Diagnostics, Sanofi, Takeda, brexit
Takeda’s acquisition of Shire finally got the go-ahead this week as 88% of shareholders voted in favour of French CEO …
Health Secretary Matt Hancock says government may charter flights to deliver medicines in case of no-deal Brexit
December 7, 2018Medical Communications Matt Hancock, NHS, UK, brexit, no-deal
British health secretary Matt Hancock has said the government is working out ways through which they could charter flights in …
83% in healthcare say UK will not be attractive for R&D and manufacturing post-Brexit
November 30, 2018Medical Communications, Research and Development R&D, UK, brexit, pharma
As the Brexit crisis continues to spiral, new findings from GlobalData reveal that 83% of healthcare professionals in the UK …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
